scholarly journals Interpersonal problems as predictors of therapeutic alliance and symptom improvement in cognitive therapy for depression

2012 ◽  
Vol 138 (3) ◽  
pp. 458-467 ◽  
Author(s):  
Fritz Renner ◽  
Robin B. Jarrett ◽  
Jeffrey R. Vittengl ◽  
Marna S. Barrett ◽  
Lee Anna Clark ◽  
...  
1994 ◽  
Vol 62 (1) ◽  
pp. 185-190 ◽  
Author(s):  
J. Christopher Muran ◽  
Zindel V. Segal ◽  
Lisa Wallner Samstag ◽  
Cynthia E. Crawford

2006 ◽  
Vol 194 (1) ◽  
pp. 15-20 ◽  
Author(s):  
John C. Markowitz ◽  
Kathryn L. Bleiberg ◽  
Paul Christos ◽  
Elizabeth Levitan

2020 ◽  
Vol 158 (6) ◽  
pp. S-905-S-906
Author(s):  
Brian M. Quigley ◽  
Christopher Radziwon ◽  
Alison Vargovich ◽  
Jeffrey M. Lackner

Psychotherapy ◽  
1999 ◽  
Vol 36 (4) ◽  
pp. 320-328 ◽  
Author(s):  
Neil A. Rector ◽  
David C. Zuroff ◽  
Zindel V. Segal

2004 ◽  
Vol 34 (4) ◽  
pp. 643-658 ◽  
Author(s):  
J. R. VITTENGL ◽  
L. A. CLARK ◽  
R. B. JARRETT

Background. Cognitive therapy reduces depressive symptoms of major depressive disorder, but little is known about concomitant reduction in social-interpersonal dysfunction.Method. We evaluated social-interpersonal functioning (self-reported social adjustment, interpersonal problems and dyadic adjustment) and depressive symptoms (two self-report and two clinician scales) in adult outpatients (n=156) with recurrent major depressive disorder at several points during a 20-session course of acute phase cognitive therapy. Consenting acute phase responders (n=84) entered a 2-year follow-up phase, which included an 8-month experimental trial comparing continuation phase cognitive therapy to assessment-only control.Results. Social-interpersonal functioning improved after acute phase cognitive therapy (dyadic adjustment d=0·47; interpersonal problems d=0·91; social adjustment d=1·19), but less so than depressive symptoms (d=1·55). Improvement in depressive symptoms and social-interpersonal functioning were moderately to highly correlated (r=0·39–0·72). Improvement in depressive symptoms was partly independent of social-interpersonal functioning (r=0·55–0·81), but improvement in social-interpersonal functioning independent of change in depressive symptoms was not significant (r=0·01–0·06). In acute phase responders, continuation phase therapy did not further enhance social-interpersonal functioning, but improvements in social-interpersonal functioning were maintained through the follow-up.Conclusions. Social-interpersonal functioning is improved after acute phase cognitive therapy and maintained in responders over 2 years. Improvement in social-interpersonal functioning is largely accounted for by decreases in depressive symptoms.


2019 ◽  
Author(s):  
Else Bisseling ◽  
Linda Cillessen ◽  
Philip Spinhoven ◽  
Melanie Schellekens ◽  
Félix Compen ◽  
...  

BACKGROUND Mindfulness-Based Cognitive Therapy (MBCT) is an evidence-based group-based psychological treatment in oncology, resulting in reduction of depressive and anxiety symptoms. Internet-based Mindfulness-based Cognitive Therapy (eMBCT) has been found to be an effective alternative for MBCT. The therapeutic alliance, i.e. the bond between therapist and patient, is known to have a significant impact on psychological treatment outcomes, including MBCT. A primary concern in the practice of eMBCT is whether a good therapeutic alliance can develop. Although evidence for the beneficial effect of therapist-assistance on treatment outcome in internet-based interventions (IBIs) is accumulating, it is still unclear whether the therapeutic alliance is related to outcome in IBIs. OBJECTIVE The objectives of the present study were: (1) to explore whether early therapeutic alliance predicts treatment dropout in (e)MBCT; (2) to compare the development of the therapeutic alliance during eMBCT and MBCT; and (3) to examine whether early therapeutic alliance is a predictor of the reduction of psychological distress and the increase of mental well-being at post-treatment in both conditions. METHODS The present study was part of a multicentre randomized controlled trial (RCT; n=245) on the effectiveness of (e)MBCT for distressed cancer patients. The therapeutic alliance was measured at the start of week 2 (i.e. early therapeutic alliance), week 5 and week 9. Outcome measures were psychological distress, measured with the Hospital Anxiety and Depression Scale (HADS) and mental-wellbeing, measured with the Mental Health Coninuum-short form (MHC-SF). RESULTS The strength of early therapeutic alliance did not predict treatment dropout in (e)MBCT (B=-0.39, p=.21). Therapeutic alliance increased over time in both conditions (F=16.46,Wilks’ λ=.732, p<.001). This increase did not differ between eMBCT and MBCT (F=0.114, p=.74). Therapeutic alliance at week 2 predicted a reduction of psychological distress (B=-.126, t=-2.656, p=.01) and an increase of in mental well-being (B=.234, t=2.651, p=.01) at post-treatment. The relationship with reduction of psychological distress differed between treatments: a weaker early therapeutic alliance predicted higher psychological distress at post-treatment in MBCT but not in eMBCT(B=.217, t=2.261, p=.03). CONCLUSIONS A therapeutic alliance can develop in both eMBCT and MBCT. Findings revealed that the strength of early alliance did not predict treatment dropout. Furthermore, the level of therapeutic alliance predicted reduced psychological distress and increased mental well-being at post-treatment in both conditions. Interestingly, the strength of therapeutic alliance is appeared to be more related to treatment outcome in group-based MBCT than in eMBCT. CLINICALTRIAL NCT02138513 https://clinicaltrials.gov/ct2/show/NCT02138513


Sign in / Sign up

Export Citation Format

Share Document